Articles

Atrium Health's Levine Children's Hospital proved to be a new trial site to test a new medicine for children that can regulate and stabilize their blood pressure in fatal circumstances.…
Read More...

Genomics England and Lantern Pharma that emphasizes on precision oncology incorporating Artificial intelligence asserted that Lantern will associate with Genomics England's Discovery…
Read More...

GT Biopharma focused on the development and commercialization of novel cancer immunotherapy products as well as central nervous system treatments asserted the appointment of Shawn M.…
Read More...

FDA has approved a certain Erleada for the treatment of patient inflicted with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with…
Read More...

PharmaMar forays into an exclusive licensing agreement with Seattle Genetics ensuring access to certain PharmaMar proprietary molecules for the development and commercialization of…
Read More...

Ace RNA medicines company, Arcturus Therapeutics asserted the appointment of Dr. Christine Esau, Senior Director of Translational Research, as Vice President of Research and…
Read More...

Charles River Laboratories International declared that it has ventured into a definitive agreement to obtain MPI Research for $800 million in cash. James C. Foster, Chairman and…
Read More...

Leading provider of nonclinical contract research services and research models, Envigo asserted the appointment of Lynn Lewis to the position of  Senior Vice President, Global Sales.…
Read More...

U.S Food and Drug Administration paved way for the marketing of the Viz.AI Contact application which is a type of clinical decision support software designed to interpret computed…
Read More...

Leading clinical trial technology and specialty services provider, Bracket declared the appointment of Michael Nolte as the company's Chief Executive Officer. Michael Nolte served as…
Read More...

Martha A.Q .Curley, PhD, RN, FAAN, a professor in Nursing Science at the University of Pennsylvania's School of Nursing, has been appointed the Ruth M. Colket Endowed Chair in Pediatric…
Read More...

Merck declared that it will rescind protocol 019 also termed as the APECS study assessing verubecestat (MK-8931), an investigational small molecule inhibitor of the beta-site amyloid…
Read More...

International contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, Cobra Biologics and Symbiosis Pharmaceutical Services asserted having clinched…
Read More...

Ambry Genetics and Invicro partner to offer customized genomics and imaging services for the pharmaceutical and biotechnology industry, exhibiting profound emphasis on Oncology and…
Read More...

Theravance Biopharma and Mylan N.V confirmed U.S Food and Drug Administration's acceptance for reviewing the company's New Drug Application (NDA) for revefenacin (TD-4208), an…
Read More...

Harris Healthcare asserts that Emerald Health Information Systems will transition from MediSolution, Harris Healthcare's sister company under the Harris umbrella, to Harris Healthcare…
Read More...

In a bid to bring on board fresh participants for its weight loss surgery surgery thus making it accessible patients with  a considerably low BMI of 30-35, New Jersey Bariatric Center…
Read More...

Leading provider of clinical trial support services, Paragon International affirmed new name "Paragon Global CRS" The name symbolizes the variety of services currently being offered by…
Read More...

Spectris plc acquires Concept Life Sciences, the integrated drug discovery, development and analytical services and environmental consultancy company. Spectris has acquired the Concept…
Read More...

European Patent Office grants Intent-to-Grant notice to biotechnology company specializing in the development of innovative drugs in oncology, in particular against rare or resistant…
Read More...